A61L24/0005

METHODS AND MATERIALS FOR TREATING TUMORS
20190298776 · 2019-10-03 ·

This document provides methods and materials for treating a mammal (e.g., a human) having one or more tumors. For example, embolic agents including an amnion tissue preparation (e.g., amnion coated embolic agents) that can be used in arterial embolization to reduce or eliminate blood flow in a blood vessel that supplies a tumor are provided.

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

The present invention relates to a pharmaceutical composition in form of emulsion or microemulsion and the use thereof as aid during endoscopic procedures in which it is injected in a target tissue in order to form a cushion. More in details, the invention relates to a method for performing an endoscopic procedure, which comprises injecting said pharmaceutical composition in form of emulsion or microemulsion in a target tissue of a patient, in order to form a cushion, which cushion is then optionally subjected to an endoscopic surgical procedure, such as a resection.

METHODS FOR ADHERING TISSUE SURFACES AND MATERIALS AND BIOMEDICAL USES THEREOF

The present invention relates to methods for adhering tissue surfaces and materials and biomedical uses thereof. In particular the present invention relates to a method for adhering a first tissue surface to a second tissue surface in a subject in need thereof, comprising the steps of adsorbing a layer of nanoparticles on at least one of the tissue surfaces, and approximating the surfaces for a time sufficient for allowing the surfaces to adhere to each other. The present invention also relates to a method for adhering a material to a biological tissue in a subject in need thereof, comprising the steps of adsorbing a layer of nanoparticles on the surface of the material and/or the biological tissue and approximating the material and the biological tissue for a time sufficient for allowing the material and the biological tissue to adhere to each other.

PULVERULENT SEMISYNTHETIC MATERIAL OBTAINED BY MODIFYING THE COMPOSITION OF A NATURAL MARINE BIOMATERIAL, METHOD OF MANUFACTURE THEREOF, AND APPLICATIONS THEREOF
20190275198 · 2019-09-12 · ·

A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacna gigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopus hippopus, Hippopus porcelanus, in pulverulent form, with the addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation.

ELECTROMAGNETIC-WAVE TREATMENT DEVICE
20190262228 · 2019-08-29 ·

The shoulder stiffness, the muscle fatigue, etc., are easily and efficiently improved by the electromagnetic waves without the usage of the power supplies and the large treatment tools. The electromagnetic-wave treatment device 10 has an antenna acupuncture needle 13 and a fixing member 12. The antenna acupuncture needle 13 has a sharp end portion 13a having one end portion formed into a needle shape. The fixing member is fixed to the antenna acupuncture needle 13. This antenna acupuncture needle 13 is fixed so that the sharp end portion 13a of the antenna acupuncture needle 13 protrudes from the fixing member 12. And, the antenna acupuncture needle 13 functions as an antenna receiving the electromagnetic waves in a space.

Radioactive liquid embolic

Liquid embolic preparations and medical treatment methods of using those preparations are described. In some embodiments, the preparations or solutions can transition from a liquid to a solid for use in the embolization. The preparations can include biocompatible polymers with covalently bound radioactive iodine isotopes.

Method of Hemostasis

A method of hemostasis includes the step of applying a hemostatic agent to an affected site of a subject, the hemostatic agent consisting of a first agent comprising a gelatin derivative having a hydrophobic group bonded to the gelatin via an imino group, wherein the gelatin derivative has (a) a weight average molecular weight of from 10,000 to 50,000, (b) the hydrophobic group, which is an alkyl group having 6 to 18 carbon atoms; and (c) a molar ratio of imino group/amino group of the gelatin derivative ranging from 1/99 to 30/70; and a second agent including a crosslinking agent for the gelatin derivative.

CELL-SEEDED POROUS LUNG HYDROGEL SEALANT

Disclosed are a biosealant system and method for treatment of a pulmonary air leak comprising applying the biosealant system to the locus of the air leak.

Pulverulent semisynthetic material obtained by modifying the composition of a natural marine biomaterial, method of manufacture thereof, and applications thereof
10342895 · 2019-07-09 · ·

A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from the group including Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacnagigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopushippopus, Hippopusporcelanus, in pulverulent form, with addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation; it also relates to the method of preparation thereof and to the uses thereof.

EXTRACELLULAR MATRIX FOR TISSUE RECONSTRUCTION OF MUCOSAL TISSUE

Described are methods and compositions for treatment of reproductive or urogenital mucosal tissue damage using Extracellular Matrix (ECM) solution and, particularly, Extracellular Matrix Hydrogel (ECMH) solution delivered to the target site for tissue repair, restoration, remodeling, or reconstruction.